A mechanism for the addition of multiple moles of glutamate by folylpolyglutamate synthetase

Journal of Medicinal Chemistry
1984.0

Abstract

The role of the alpha-carboxyl group in methotrexate (MeAPA-Glu) and the gamma-glutamate derivative of methotrexate (MeAPA-Glu-Glu) in the reaction catalyzed by folylpolyglutamate synthetase (FPGS) has been investigated. MeAPA-Glu and MeAPA-Glu-Glu were accepted as substrates by the same FPGS species contained in an (NH4)2SO4 precipitate of mouse liver protein, as judged by a lack of additivity of product formation at saturating concentrations of both substrates. MeAPA-Gaba, the MeAPA-Glu analogue lacking an alpha-carboxyl, was inactive as a substrate for this enzyme as was MeAPA-Glu-Gaba, the analogue of MeAPA-Glu-Glu that lacked the alpha-carboxyl of the terminal glutamic acid. However, MeAPA-Gaba-Glu, the analogue of MeAPA-Glu-Glu without an alpha-carboxyl on the first glutamic acid, had activity as a substrate for FPGS that approached that of MeAPA-Glu-Glu. These results suggest that the alpha-carboxyl is essential for the binding of folyl monoglutamates to FPGS in the correct orientation to allow catalysis. Moreover, the binding of the terminal alpha-carboxyl of folyl oligoglutamates to the same residue(s) responsible for the binding of the alpha-carboxyl of folyl monoglutamates would allow correct positioning of the terminal gamma-carboxyl of the chain for reaction. This binding mechanism would be compatible with the utilization of a single enzyme species for the addition of glutamate to the monoglutamate or oligoglutamate forms of folates and folate analogues.

Knowledge Graph

Similar Paper

A mechanism for the addition of multiple moles of glutamate by folylpolyglutamate synthetase
Journal of Medicinal Chemistry 1984.0
Design and Synthesis of Histidine Analogues of Folic Acid and Methotrexate as Potential Folylpolyglutamate Synthetase Inhibitors
Journal of Medicinal Chemistry 1996.0
Synthesis of N-[N-(4-deoxy-4-amino-10-methylpteroyl)-4-fluoroglutamyl]-.gamma.-glutamate, an unusual substrate for folylpoly-.gamma.-glutamate synthetase and .gamma.-glutamyl hydrolase
Journal of Medicinal Chemistry 1990.0
Synthesis and Biological Activity of Folic Acid and Methotrexate Analogues Containing <scp>l</scp>-threo-(2S,4S)-4-Fluoroglutamic Acid and <scp>dl</scp>-3,3-Difluoroglutamic Acid
Journal of Medicinal Chemistry 1996.0
Folic acid analogs lacking the 2-carbon are substrates for folylpolyglutamate synthetase and inhibit cell growth
Journal of Medicinal Chemistry 1991.0
Methotrexate analogs. 26. Inhibition of dihydrofolate reductase and folylpolyglutamate synthetase activity and in vitro tumor cell growth by methotrexate and aminopterin analogs containing a basic amino acid side chain
Journal of Medicinal Chemistry 1986.0
Synthesis and Biological Evaluation of<scp>dl</scp>-4,4-Difluoroglutamic Acid and<scp>dl</scp>-γ,γ-Difluoromethotrexate
Journal of Medicinal Chemistry 1996.0
Syntheses of .alpha.- and .gamma.-substituted amides, peptides, and esters of methotrexate and their evaluation as inhibitors of folate metabolism
Journal of Medicinal Chemistry 1982.0
Methotrexate analogs. 29. Effect of .gamma.-aminobutyric acid spacers between the pteroyl and glutamate moieties on enzyme binding and cell growth inhibition
Journal of Medicinal Chemistry 1986.0
Methotrexate analogs. 20. Replacement of glutamate by longer-chain amino diacids: Effects on dihydrofolate reductase inhibition, cytotoxicity, and in vivo antitumor activity
Journal of Medicinal Chemistry 1983.0